Results 11 to 20 of about 68,801 (240)
Controversies in Thrombolysis [PDF]
Current Neurology and Neuroscience Reports, 2017 The purpose of the review is to examine recent evidence on the effects of intravenous thrombolysis and identify the remaining uncertainties.We review the results of two large trials (the third International Stroke Trial (IST-3) and The Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)) and the publications from the individual ...
Sandercock, Peter A. G., Ricci, Stefano
openaire +2 more sources
British Medical Bulletin, 2000 The most widely studied thrombolytic drugs in stroke have been streptokinase (SK) and alteplase. The three large trials with streptokinase were terminated prematurely. The combined results reveal an early increased risk of cerebral haemorrhage and death, with no net benefit at final follow-up, even in subgroups. Some controversy persists, however.
openaire +2 more sources
Multidisciplinary Approach to Decrease In-Hospital Delay for Stroke Thrombolysis [PDF]
Journal of Stroke, 2017 Background and Purpose Decreasing the time delay for thrombolysis, including intravenous thrombolysis (IVT) with tissue plasminogen activator and intra-arterial thrombectomy (IAT), is critical for decreasing the morbidity and mortality of patients ...
Sang-Beom Jeon +20 more
doaj +1 more source
PRE-HOSPITAL THROMBOLYSIS IN KRASNOYARSK: RESULTS OF A RETROSPECTIVE COMPARATIVE STUDY
Рациональная фармакотерапия в кардиологии, 2016 Aim. To compare the safety and efficacy of pre-hospital thrombolysis with tenecteplase and hospital thrombolysis with alteplase. Material and Methods. Pre-hospital thrombolytic therapy with tenecteplase (n=15) and hospital thrombolysis with alteplaza (n ...
S. A. Skripkin +4 more
doaj +1 more source
Effects of thrombolysis on outcomes of patients with deep venous thrombosis: An updated meta-analysis. [PDF]
PLoS ONE, 2018 BACKGROUND:Small randomized controlled studies and meta-analyses have shown that thrombolysis, especially catheter-directed thrombolysis, can reduce the incidence of post-thrombotic syndrome (PTS).
Zhenhua Xing +3 more
doaj +1 more source
Radiology Case Reports, 2018 Pulmonary embolism is a life-threatening condition treated with anticoagulation and systemic thrombolysis when appropriate. In patients with contraindications to thrombolysis, catheter-directed thrombolysis may be considered.
Steve M. Nelson, MD, Steven H. Craig, MD
doaj +1 more source
Journal of Family Medicine and Primary Care, 2020 Background: Although intravenous (IV) thrombolysis is an effective treatment for patients with acute ischemic stroke (AIS), it remains underused by neurologists worldwide. This study assessed the knowledge and attitudes toward IV thrombolysis in patients
Fatimah Ali Alharbi +3 more
doaj +1 more source
Chinese Journal of Contemporary Neurology and Neurosurgery, 2023 Objective To determine if rt ⁃ PA intravenous thrombolysis has distinct short ⁃ term effects on individuals of different ages with acute ischemic stroke.
WANG Jing, ZHANG Guo⁃fu
doaj +1 more source
Ultrasound and thrombolysis [PDF]
Vascular Medicine, 2001 Thrombolytic therapy and mechanical interventions are frequently used in the treatment of both arterial and venous thrombotic disease. Limitations to these approaches include failure to achieve reperfusion and complications including bleeding and vessel wall damage.
C W, Francis, V N, Suchkova
openaire +2 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground Epistaxis is common with antithrombotic therapy and is often troublesome to patients, yet its frequency, severity, and outcomes are poorly characterized.
Robert S. Semco +9 more
doaj +1 more source